Abstract:Editor, Dose, concentration and volume of local anaesthetics have been described as a ‘triangulated circular argument’.1 It is then necessary to fix one variable to evaluate the others for dose-finding studies in regional anaesthesia. We previously used a fixed volume of 40 ml and found that 0.257 and 0.273%wt vol−1 were the minimum effective concentrations (MECs) in 90 and 99% of patients, respectively, of ropivacaine for ultrasound-guided supraclavicular block (SCB).2 In this follow-on study, we use 0.275%wt vol−1 as the MEC99 with the aim of estimating the minimum effective volume in 90% of patients (MEV90) using an up-down sequential allocation biased coin design (BCD). After obtaining local clinical trial ethics committee approval and written informed consent, we prospectively enrolled a minimum of 45 patients aged 41 to 65 years undergoing elective unilateral upper limb surgery from May to October 2015 at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (NCT02512471). All participants received double-injection ultrasound-guided SCB using 0.275%wt vol−1 ropivacaine (Naropin; AstraZeneca AB, Sodertalje, Sweden) with a protocol similar to our previous study.2 Half the volume was deposited in the ‘corner pocket’ after repeated aspiration, and the remainder was injected at the centre of the main neural cluster formed by the brachial plexus, using the compressed air injection technique.3 The starting volume and testing interval were 24 and 2 ml, respectively. The volumes were determined by the responses of previous patients with a failed block being followed by an increment for the next participant. After a successful block, the next patient was randomised to the same volume or a decrement with probabilities of 0.89 or 0.11, respectively. Success was defined as complete sensory blockade of the brachial plexus at 30 min and pain-free surgery. MEV90 was estimated using isotonic regression and the 95% confidence interval (95% CI) with 2000 bootstrap replicates using R version 3.6.1 (2019 The R Foundation for Statistical Computing, Vienna, Austria; ISBN 3-900051-07-0, http://www.r-project.org).4 The results for the 53 patients are shown in Fig. 1. MEV90 was 30.2 ml (95% CI 28.1 to 33.8). MEV95 was 31.1 ml (95% CI 29.6 to 33.6) and MEV99 was 31.8 ml (95% CI 30.7 to 33.6). Successful blocks (n = 45) resulted in satisfactory surgical anaesthesia. All failed blocks (n = 8) responded to local infiltration or rescue blocks without conversion to general anaesthesia. There were no pneumothoraces or vascular punctures.Fig. 1: Up-down biased coin design sequence of blocks with different ropivacaine volumes. The horizontal line is the calculated minimum effective volume of ropivacaine providing successful supraclavicular block in 90% of patients (MEV90); error bars represent 95% CI.We believe that this is the first study investigating the MEV90 of ropivacaine for SCB. This study completes a two-step strategy to find the best combination of concentration and volume that may be applicable to different clinical settings. We found that 32 ml was the lowest volume for a 100% success of ultrasound-guided SCB, fitting well in the range of 30 to 40 ml, which is generally believed to obtain dependable surgical anaesthesia. Thus, an optimal dose of ropivacaine is 0.275%wt vol−1 × 32 ml = 88.0 mg. Gupta and Hopkins5 used a Dixon small sample method to find the median effective volumes of three different concentrations of bupivacaine for ultrasound-guided SCB. They found that the ED50 of bupivacaine was independent of concentration. However, we did not find this at ED90. For 0.257%wt vol−1 ropivacaine, the ED90 is 0.257%wt vol−1 × 40 ml = 102.8 mg (95% CI 96.4 to 112),2 while for 0.275%wt vol−1 ropivacaine, the ED90 is 0.275%wt vol−1 × 30.2 ml = 83.05 mg (95% CI 77.3 to 93.0). The lack of overlap in the 95% CIs indicates a significant difference between the two ED90 results. Thus ED90, unlike ED50, is clearly dependent on the concentration of local anaesthetics. This disagreement may be explained by the inaccurate estimation of high quantiles far from the midpoint by the Dixon-Mood method.6 A single experienced anaesthetist performed all the blocks, which may limit the generalisability of our results. Also, caution should be exercised when studies with different criteria of block success are compared. In conclusion, an optimal dose of ropivacaine for double-injection ultrasound-guided SCB in middle-aged adults is 0.275%wt vol−1 × 32.0 ml = 88.0 mg.

Minimum Effective Concentration of Ropivacaine for Ultrasound-Guided Transmuscular Quadratus Lumborum Block in Total Hip Arthroplasty: a Randomized Clinical Trial.

Minimum Effective Concentration of Ropivacaine for Ultrasound-Guided Adductor Canal + IPACK Block in Total Knee Arthroplasty

Minimum Effective Volume of Ropivacaine for Ultrasound-Guided Adductor Canal + IPACK Block in Total Knee Arthroplasty: A Double-Blind, Randomized Dose-Finding Trial

Determining the Minimum Effective Concentration of Ropivacaine in Epidural Anesthesia for Tolerable Pain in Transforaminal Percutaneous Endoscopic Lumbar Discectomy to Avoid Nerve Injury: A Double-Blind Study Using a Biased-Coin Design.

Lack of Sex Difference in Minimum Local Analgesic Concentration of Ropivacaine for Ultrasound-Guided Supraclavicular Brachial Plexus Block

The analgesic efficacy of subcostal transversus abdominis plane block with Mercedes incision

The median effective concentration of ropivacaine for ultrasound-guided anterior iliopsoas muscle space block in the elderly undergoing hip surgery: a dose-finding study

The Median Effective Analgesic Concentration of Ropivacaine in Sciatic Nerve Block Guided by Ultrasound After Arthroscopic Anterior Cruciate Ligament Reconstruction: A Double-Blind Up-Down Concentration-Finding Study

The Minimum Effective Concentration (MEC90) of Ropivacaine for Ultrasound-Guided Supraclavicular Brachial Plexus Block

An Optimal Dose of Ropivacaine for Ultrasound-Guided Supraclavicular Brachial Plexus Block

Effects of Different Volumes of Ropivacaine for Pericapsular Nerve Group Block on Incidence of Quadriceps Weakness and Analgesic Efficacy Following Hip Arthroplasty: A Randomized Controlled Trial

Different Concentrations of Ropivacaine under Ultrasound Guidance on Quadratus Lumbar Muscle Nerve Block in Elderly Patients with Hip Replacement

Effects of a fixed low-dose ropivacaine with different volume and concentrations on interscalene brachial plexus block: a randomized controlled trial

Effect of low-volume ropivacaine in ultrasound-guided superior trunk block on diaphragmatic movement in patients undergoing shoulder arthroscopy: a randomized controlled trial

The Median Effective Volume of 0.375% Ropivacaine for Ultrasound-guided Anterior Suprascapular Nerve Block in Arthroscopic Shoulder Surgery.

The minimum effective concentration (MEC90) of ropivacaine for ultrasound-guided caudal block in anorectal surgery. A dose finding study

Effect of bupivacaine concentration on ultrasound-guided pericapsular group nerve block efficacy in hip surgery patients: comparative, randomized, double-blinded clinical trial

Evaluation of Rhomboid Intercostal Block in Video-Assisted Thoracic Surgery: Comparing Three Concentrations of Ropivacaine

Effects of Ropivacaine Concentration on Analgesia After Ultrasound-Guided Serratus Anterior Plane Block: A Randomized Double-Blind Trial

Effect of Pericapsular Nerve Group Block with Different Concentrations and Volumes of Ropivacaine on Functional Recovery in Total Hip Arthroplasty: A Randomized, Observer-Masked, Controlled Trial

Comparison of Different Concentrations of Ropivacaine Used for Ultrasound-Guided Adductor Canal Block + IPACK Block in Total Knee Arthroplasty.